Spectral Diagnostics Research and Development Expenses 2010-2025 | EDTXF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Spectral Diagnostics research and development expenses from 2010 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.

Spectral Diagnostics Research and Development Expenses 2010-2025 | EDTXF

Prices Financials Revenue & Profit Assets & Liabilities Margins Price Ratios Other Ratios Other Metrics

Revenue Gross Profit Operating Income EBITDA Net Income Shares Outstanding

Spectral Diagnostics research and development expenses from 2010 to 2025. Research and development expenses can be defined as an expense arising from studies and product development processes.

Related Stocks
Company Name	Market Cap
Intuitive Surgical (ISRG)	$185.9B
Thermo Fisher Scientific (TMO)	$156.6B
Edwards Lifesciences (EW)	$44.9B
Alcon (ALC)	$43.1B
IDEXX Laboratories (IDXX)	$41.4B
DexCom (DXCM)	$32.9B
IQVIA Holdings (IQV)	$27.8B
Mettler-Toledo (MTD)	$24.8B
STERIS (STE)	$22.2B
SONOVA HOLDING (SONVY)	$17.4B
Waters (WAT)	$17.1B
Hologic (HOLX)	$14.3B
Sysmex ADR (SSMXY)	$10.4B
Penumbra (PEN)	$8.9B
Masimo (MASI)	$8.4B
Globus Medical (GMED)	$7.6B
Glaukos (GKOS)	$5.6B
Teleflex (TFX)	$4.9B
Integer Holdings (ITGR)	$3.9B
TransMedics (TMDX)	$3.7B
PROCEPT BioRobotics (PRCT)	$3.2B
LivaNova (LIVN)	$2.3B
Elekta AB (EKTAY)	$1.9B
Nihon Kohden (NHNKY)	$1.9B
Veracyte (VCYT)	$1.8B
Alphatec Holdings (ATEC)	$1.5B
Artivion (AORT)	$1.3B
Paragon 28 (FNA)	$1.1B
OPKO Health (OPK)	$1.1B
Pulse Biosciences (PLSE)	$1B